Infertility in male transgenic mice: disruption of sperm development by HSV-tk expression in postmeiotic germ cells. 1990

R E Braun, and D Lo, and C A Pinkert, and G Widera, and R A Flavell, and R D Palmiter, and R L Brinster
Department of Biochemistry, Howard Hughes Medical Institute, University of Washington, Seattle 98195.

Previous experiments revealed that male transgenic mice bearing a cosmid that included the Class II E alpha gene, about 35 kb of 5' flanking DNA, and the cosmid vector sequences were sterile. To ascertain the cause of the sterility, various subfragments of the cosmid were tested in transgenic mice. Only those pieces of DNA that included some of the E alpha flanking chromosomal DNA and the herpes simplex virus (HSV)-thymidine kinase (tk) gene that was in the vector resulted in male sterility. Histological analysis revealed abnormalities in nuclear morphology of elongating spermatids and retention of mature spermatids within the seminiferous epithelium. Immunocytochemical studies showed that the HSV-tk gene was expressed at low levels in postmeiotic round spermatids and at higher levels in more mature elongating spermatids. To determine whether expression of HSV-tk in spermatids might be responsible for the sterility, the protamine gene promoter was used to direct the expression of HSV-tk to postmeiotic germ cells. Since the mice so treated were also sterile, the data suggest that expression of this enzyme in spermatids is responsible for the sterility phenotype.

UI MeSH Term Description Entries
D007248 Infertility, Male The inability of the male to effect FERTILIZATION of an OVUM after a specified period of unprotected intercourse. Male sterility is permanent infertility. Sterility, Male,Sub-Fertility, Male,Subfertility, Male,Male Infertility,Male Sterility,Male Sub-Fertility,Male Subfertility,Sub Fertility, Male
D008297 Male Males
D008540 Meiosis A type of CELL NUCLEUS division, occurring during maturation of the GERM CELLS. Two successive cell nucleus divisions following a single chromosome duplication (S PHASE) result in daughter cells with half the number of CHROMOSOMES as the parent cells. M Phase, Meiotic,Meiotic M Phase,M Phases, Meiotic,Meioses,Meiotic M Phases,Phase, Meiotic M,Phases, Meiotic M
D008822 Mice, Transgenic Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN. Transgenic Mice,Founder Mice, Transgenic,Mouse, Founder, Transgenic,Mouse, Transgenic,Mice, Transgenic Founder,Transgenic Founder Mice,Transgenic Mouse
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D011479 Protamines A group of simple proteins that yield basic amino acids on hydrolysis and that occur combined with nucleic acid in the sperm of fish. Protamines contain very few kinds of amino acids. Protamine sulfate combines with heparin to form a stable inactive complex; it is used to neutralize the anticoagulant action of heparin in the treatment of heparin overdose. (From Merck Index, 11th ed; Martindale, The Extra Pharmacopoeia, 30th ed, p692) Protamine,Protamine Sulfate,Protamine Chloride,Chloride, Protamine,Sulfate, Protamine
D002874 Chromosome Mapping Any method used for determining the location of and relative distances between genes on a chromosome. Gene Mapping,Linkage Mapping,Genome Mapping,Chromosome Mappings,Gene Mappings,Genome Mappings,Linkage Mappings,Mapping, Chromosome,Mapping, Gene,Mapping, Genome,Mapping, Linkage,Mappings, Chromosome,Mappings, Gene,Mappings, Genome,Mappings, Linkage
D003001 Cloning, Molecular The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells. Molecular Cloning
D003360 Cosmids Plasmids containing at least one cos (cohesive-end site) of PHAGE LAMBDA. They are used as cloning vehicles. Cosmid
D005260 Female Females

Related Publications

R E Braun, and D Lo, and C A Pinkert, and G Widera, and R A Flavell, and R D Palmiter, and R L Brinster
January 2006, Physiological genomics,
R E Braun, and D Lo, and C A Pinkert, and G Widera, and R A Flavell, and R D Palmiter, and R L Brinster
May 1989, Molecular and cellular biology,
R E Braun, and D Lo, and C A Pinkert, and G Widera, and R A Flavell, and R D Palmiter, and R L Brinster
January 2009, Reproductive toxicology (Elmsford, N.Y.),
R E Braun, and D Lo, and C A Pinkert, and G Widera, and R A Flavell, and R D Palmiter, and R L Brinster
March 1988, Biochemical and biophysical research communications,
R E Braun, and D Lo, and C A Pinkert, and G Widera, and R A Flavell, and R D Palmiter, and R L Brinster
September 2017, Endocrinology,
R E Braun, and D Lo, and C A Pinkert, and G Widera, and R A Flavell, and R D Palmiter, and R L Brinster
November 2001, Proceedings of the National Academy of Sciences of the United States of America,
R E Braun, and D Lo, and C A Pinkert, and G Widera, and R A Flavell, and R D Palmiter, and R L Brinster
May 2005, The FEBS journal,
R E Braun, and D Lo, and C A Pinkert, and G Widera, and R A Flavell, and R D Palmiter, and R L Brinster
October 2004, Biology of reproduction,
R E Braun, and D Lo, and C A Pinkert, and G Widera, and R A Flavell, and R D Palmiter, and R L Brinster
December 2017, International journal of molecular sciences,
R E Braun, and D Lo, and C A Pinkert, and G Widera, and R A Flavell, and R D Palmiter, and R L Brinster
January 1982, Cytogenetics and cell genetics,
Copied contents to your clipboard!